Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benbus Cap.
- Development stage
- Unknown
- Lead developer
- Globus Remedies
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Benbus Cap. (also marketed as Benbus-3) is an oral dietary supplement capsule manufactured and marketed by Globus Remedies. It is formulated as a fixed-dose combination of vitamin E, omega-3 fatty acids, and wheat germ oil. The supplement is designed to support cardiovascular health, enhance immune function, provide antioxidant protection, and promote skin and hair health. Vitamin E acts as a fat-soluble antioxidant to protect cells from oxidative stress, omega-3 fatty acids support heart and vascular function, and wheat germ oil provides a natural source of essential lipids and bioactive nutrients.
- Brand names
- Benbus 3Benbus3Benbus-3Benbus 3 Soft Gelatin CapsuleBenbus3 Soft Gelatin CapsuleBenbus-3 Soft Gelatin CapsuleBenbus Cap.
- Other names
- omega-3 fatty acids + vitamin E + wheat germ oil
Beyond the preview
Go deeper on Benbus Cap..
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Benbus Cap..